Ikuo Tsunoda is an expert in Immunology at Kindai University (Japan). Ikuo Tsunoda has authored 140 publications, the most recent in 2026. SLR score: 437 (community average: 125). How the SLR is computed.

LeadR Profile

Ikuo Tsunoda Kindai University Japan
437 ScienceLeadR Reputation 437
Network Map

Immunology

Subspecialties: Oncology - Biochemistry - Veterinary Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Ikuo Tsunoda obtained his MD and PhD degrees from Tohoku University School of Medicine, Sendai, Japan. He continued his research on multiple sclerosis (MS) as a Research Associate at Tohoku University School of Medicine. He trained as a Neurology resident for 2 years under Teiji Yamamoto, MD, Professor at Fukushima Medical University. He also trained in neuropathology under Yuzo Iwasaki, MD, PhD, Professor, at Tohoku University School of Medicine. In 1995, he started working at the Department of Neurology, University of Utah, as a Postdoctoral fellow in Dr. Robert S. Fujinami’s laboratory. At the University of Utah, he was offered a position as a Research Associate in 1999, an Instructor in 2002, and an Assistant Professor in 2005 in the Department of Neurology, and moved to the Department of Pathology as an Assistant Professor in 2007. In 2009, he relocated his laboratory to the Department of Microbiology and Immunology at the Louisiana State University Health Sciences Center at Shreveport as an Assistant Professor. In 2015, he was promoted to Associate Professor. He has been certified by the Educational Commission for Foreign Medical Graduates (ECFMG)in the US. In 2016, he relocated his laboratory to Japan and became Professor and Chair at the Department of Microbiology, Kindai (Kinki) University Faculty of Medicine, Osaka. His research topics mainly include experimental autoimmune encephalomyelitis, HPV vaccines, Theiler’s murine encephalomyelitis virus (TMEV), and microbiota.

Organizations

Career arc: 1994 - 2026

Source: PubMed

Kindai University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 140

Citations

Citations: 3 830 1st author: 31 Last author: 49 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Long-term CT and US imaging of canine prostatic carcinoma after prostatic artery embolization: a 900-day follow-up case report.
PMID 42866543 — microspheres, prostate, arteries, prostatic neoplasms, therapeutics, wounds and injuries, endovascular procedures
Front Vet Sci20260
Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience.
PMID 42029552 — safety, poliomyelitis, vaccines, uterine cervical neoplasms, neoplasms, vaccination, autoimmune diseases, alphapapillomavirus, vaccination hesitancy, human papillomavirus viruses
Pathophysiology20260
The Safety of Alcaligenes Lipid A in a Virus-Induced Immune Disease Model Associated with IgA, Th17 Cells, and Microbiota.
PMID 41754498 — cells, lipid a, safety, immunohistochemistry, vaccines, virology, alcaligenes, vaccination, immunoglobulin a, immune system diseases, viruses, autoimmune diseases, th17 cells, bacteria, microbiota
Viruses20260
Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis.
PMID 41507632 — autoantibodies, respiratory syncytial viruses, epitopes, leukocyte l1 antigen complex, vaccines, antibodies, molecular mimicry, neoplasms, vaccination, drug-related side effects and adverse reactions, viruses, alphapapillomavirus, human papillomavirus viruses
Int J Clin Oncol20262
Flavivirus-based bivalent nanoparticle vaccines induce neutralizing antibodies and Th1 responses against flavivirus and coupling antigens.
PMID 41210957 — parvovirus b19, human, sars-cov-2, vaccines, parvovirus, antibodies, nanoparticles, antibodies, neutralizing, viruses, natural science disciplines, flavivirus, nanovaccines
iScience20250

LeadR Networks

Main global connection map